Announcements View by year: All 2025 2024 2023 2021 Filter 04 Sep 2025 Pi Health Partners with Australian Biotech Filamon to Accelerate Clinical Development of Next-Generation Anti-Inflammatory Drugs 02 Jul 2025 Filamon Unveils Novel Immune Checkpoint Inhibitor Candidate 16 Jun 2025 Filamon Makes Progress in Developing an Oral Anti-Inflammatory Drug for Eye Diseases 17 Apr 2025 April 2025: Shareholder Update 13 Mar 2025 Filamon to present at NWR Virtual Healthcare Conference 07 Feb 2025 Newsletter – February 2025 05 Feb 2025 Filamon Secures Approval for Kesonotide Clinical Trial as New Initiative for Treatment of Advanced Cancers 26 Nov 2024 Major Australian drug discovery opens way for a more effective approach to the treatment of dementia 07 Nov 2024 Details of 2024 Annual General Meeting and shareholder events Investors Announcements Corporate Presentations Glossary of Medical Terms Corporate Governance
04 Sep 2025 Pi Health Partners with Australian Biotech Filamon to Accelerate Clinical Development of Next-Generation Anti-Inflammatory Drugs
05 Feb 2025 Filamon Secures Approval for Kesonotide Clinical Trial as New Initiative for Treatment of Advanced Cancers
26 Nov 2024 Major Australian drug discovery opens way for a more effective approach to the treatment of dementia
